


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-23.69%
+2.84%
+12.48%
+9.66%
+6.22%
SYK
Stryker
$358.29
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Risk Analysis

Trading above its fair value
SYK Price Performance
$367.54 (-2.52%)
$363.7 (-1.49%)
$377.11 (-4.99%)
$387.92 (-7.64%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value

Outperform the market
![]()
SYK Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SYK Street Sentiment is extremely bullish and have positive views on the near-term outlook
SYK has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 06, 2026
Upgrade
Outperform
Raymond James
Dec 22, 2025
Reiterate
Buy
Citi
Dec 19, 2025
Reiterate
Hold
Truist Securities
Dec 12, 2025
Reiterate
Buy
Citigroup
Nov 15, 2025
Reiterate
Hold
Truist Securities
BSX
Boston Scientific
76.27
-1.76%
IART
Integra LifeSciences
11.26
+3.49%
TFX
Teleflex Incorporate
108.42
+2.40%
PROF
Profound Medical Cor
6.49
+2.69%
PAVM
PAVmed
10.80
+2.08%
What is SYK current stock price?
What are SYK stock strengths?
What is SYK Risk Level?
What is SYK market cap and volume?
What is SYK current Stock IQ?
Should I buy SYK stock right now?
Is SYK a Strong Buy right now?
What does a 'Strong Buy' rating mean for SYK?
What does a 'Strong Sell' rating mean for SYK?
What factors influence SYK's Stock IQ?
Join over 5,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-23.69%
+2.84%
+12.48%
+9.66%
+6.22%
SYK
Stryker
Current Price
$358.29
Runners Also Watch
BSX
Boston Scientific
76.27
-1.76%
IART
Integra LifeSciences
11.26
+3.49%
TFX
Teleflex Incorporate
108.42
+2.40%
PROF
Profound Medical Cor
6.49
+2.69%
PAVM
PAVmed
10.80
+2.08%

SYK Price Performance
$367.54 (-2.52%)
$363.7 (-1.49%)
$377.11 (-4.99%)
$387.92 (-7.64%)
SYK Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value

Outperform the market
![]()
SYK Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SYK Street Sentiment is extremely bullish and have positive views on the near-term outlook
SYK has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 06, 2026
Upgrade
Outperform
Raymond James
Dec 22, 2025
Reiterate
Buy
Citi
Dec 19, 2025
Reiterate
Hold
Truist Securities
Dec 12, 2025
Reiterate
Buy
Citigroup
Nov 15, 2025
Reiterate
Hold
Truist Securities
Nov 15, 2025
Reiterate
Overweight
Wells Fargo
SYK Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market
Risk Analysis

Trading above its fair value
SYK Latest Analysis
Witnessing An Insider Decision Spencer S Stiles Exercises Options Valued At $3.70M At Stryker. Highlighted on February 4 it was unveiled in an SEC filing that Stiles President and COO at ) executed a significant transaction involving the exercise of company stock options.United States Securities and Exchange Commission revealed that Stiles President and COO at Stryker exercised stock options for 13840 shares of SYK resulting in a transaction value of $3697494.Currently Stryker designs manufactur
Thu Feb 5, 2026
Stryker declares $0.88 dividend.
Wed Feb 4, 2026
Stryker declares an $0.88 per share quarterly dividend . Portage Michigan Feb. 04 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable April 30 2026 to shareholders of record at the close of business on March 31 2026 representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.
Wed Feb 4, 2026
Stryker projects 8%–9.5% organic sales growth for 2026 while advancing margin expansion and new product launches.
Fri Jan 30, 2026
Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates. Stryker (SYK) delivered earnings and revenue surprises of 1.71% and 0.61% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Jan 29, 2026
Stryker raises annual profit forecast on strong sales for medical devices.
Thu Jan 29, 2026
Stryker Corp. Q4 Profit Rises . (RTTNews) - Stryker Corp. (SYK) announced earnings for its fourth quarter that Increases from the same period last year
Thu Jan 29, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.